CVE-2015-3965: Pfizer Symbiq Infusion System Firmware

High severity, CVSS 8.8. EPSS: 2.9% chance of exploitation in the next 30 days.

Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.

Affected products

• Pfizer Symbiq Infusion System Firmware: up to and including 3.13

Published 2019-03-23. Last modified 2026-06-17.